Continuous Glucose Monitoring: Understanding the Pharmacist's Role in Patient Education and Improving Outcomes in Diabetes Management

Continuous Glucose Monitoring: Understanding the Pharmacist’s Role in Patient Education and Improving Outcomes in Diabetes Management

Faculty

Curtis L. Triplitt, PharmD
Clinical Associate Professor
University of Texas Health Science Center at San Antonio
Associate Director
Diabetes Research Unit
Texas Diabetes Institute, University Health System
San Antonio, Texas

Susan Cornell, Pharm.D, CDCES, FAPhA, FADCES
Associate Director of Experiential Education
Associate Professor of Pharmacy Practice
Midwestern University College of Pharmacy – Downers Grove, IL
Diabetes Care and Education Specialist
Bolingbrook Christian Health Clinic
Bolingbrook, Illinois
 
Program Description
Since their inception about 20 years ago, continuous glucose monitoring (CGM) has evolved immensely, with personal use CGM becoming more prevalent in the past 4 to 5 years. CGM devices afford patients the ability to measure and track their blood glucose levels throughout the day. The American Diabetes Association (ADA) has recommended the use of CGM devices in patients with diabetes to improve glucose control and assist in achieving glycemic goals. This introduction to the CGM Continuing the Conversation Curriculum will explore the past, present and future considerations for CGM technologies. Two pharmacist experts in diabetes management will discuss their clinical experience with CGM technology, explain how community pharmacists can help patients seeking information about CGM, and offer considerations for the next frontiers for CGM technology.

Target Audience: Pharmacists
Type of Activity: Knowledge
Release date: April 30, 2021
Expiration date: April 30, 2022
Time to complete activity: 0.5 hour
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Describe the use of continuous glucose monitoring (CGM) in diabetes management and ADA/AACE recommendations
• Recognize the role of the pharmacist in providing education related to the use of CGM devices and interpreting CGM data

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-185-H01-P. The activity is available for CE credit through April 30, 2022.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must listen to the podcast in its entirety and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Curtis L. Triplitt, PharmD, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Bayer
Speaker’s Bureau: Eli Lilly, Novo Nordisk, Inc.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, has the following relevant financial relationships with commercial interests to disclose:
Speaker’s Bureau: Novo Nordisk, Inc.
Other Support: Advanced Practitioner Advisory Board- Novo Nordisk, Inc.

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD, CHCP; Crissy Wilson; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms